XAVIER ALDEGUER MANTE

Projectes

Unraveling the influence of gut microbiota and derived metabolites on major depression: A cross-sectional neuroimaging-metabolomics study based on knowledge transfer from irritable bowel syndrome (IBS) and a porcine model: MOODGUT

Codi oficial: 409/C/2022 Data inicio:13/01/2023 Data fi: 13/01/2028 Investigador/a principal: JESÚS LIBRADO GARCÍA GIL, JOSEP ORIOL MIQUEL CUSACHS Organisme finançador: FUNDACIO LA MARATO TV3 Ajuda: 86,625 €

Enfermedades Digestivas y Microbiota

Ajuts per donar suport a les activitats dels grups de recerca de Catalunya (SGR-Cat 2021) - Malalties digestives i microbiota

Codi oficial: 2021 SGR 01366 Data inicio:01/01/2022 Data fi: 31/12/2024 Investigador/a principal: ROBERT CARRERAS TORRES Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER. Ajuda: 0 €

Publicacions

Enfermedades Digestivas y Microbiota

Uchima H, Blé M, Busquets D, Serra I, López C, Aldeguer X, Huertas C

Eradication of neoplastic Barrett's esophagus in patients with esophageal varices with a modified endoscopic mucosal resection technique and radiofrequency ablation

Endoscopy, 2022, 54, 261-263 dx.doi.org/10.1055/a-1516-3400

Enfermedades Digestivas y Microbiota

Riestra, S, Taxonera, C, Zabana, Y, Carpio, D, Chaparro, M, Barrio, J, Rivero, M, Lopez-Sanroman, A, Esteve, M, de Francisco, R, Bastida, G, Garcia-Lopez, S, Manosa, M, Martin-Arranz, MD, Perez-Calle, JL, Guardiola, J, Munoz, F, Arranz, L, Cabriada, JL, Garcia-Sepulcre, MF, Navarro, M, Montoro-Huguet, MA, Ricart, E, Bermejo, F, Calvet, X, Piqueras, M, Garcia-Planella, E, Marquez, L, Minguez, M, Van Domselar, M, Bujanda, L, Aldeguer, X, Sicilia, B, Iglesias, E, Alcain, G, Perez-Martinez, I, Rolle, V, Castano-Garcia, A, Gisbert, JP, Domenech, E

Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU

Journal of Clinical Medicine, 2022, 11 dx.doi.org/10.3390/jcm11133915

Enfermedades Digestivas y Microbiota

Batista, G, Marin-Jimenez, I, Fores, A, Garcia-Planella, E, Arguelles-Arias, F, Tagarro, I, Fernandez-Nistal, A, Montoto, C, Aparicio, J, Aguas, M, Santos-Fernandez, J, Bosca-Watts, MM, Ferreiro-Iglesias, R, Merino, O, Aldeguer, X, Corttes, X, Sicilia, B, Mesonero, F, Barreiro-de Acosta, M

Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study

DIGESTIVE AND LIVER DISEASE, 2022, 54, 76-83 dx.doi.org/10.1016/j.dld.2021.06.005

Enfermedades Digestivas y Microbiota

Oliveras B, Albert M, López C, Fort E, Peries L, Gutiérrez L, Busquets D, Uchima H, Aldeguer X, Piñol V

A case report of gastrointestinal histoplasmosis in a patient treated with infliximab

Clinical Journal of Gastroenterology, 2021, 14, 690-692 dx.doi.org/10.1007/s12328-020-01298-y

Patología Cerebrovascular , Privado: Envejecimiento, Discapacidad y Salud , Imagen Médica , Neurodegenerativas y neuroinflamación , Salud Mental y Adicciones , Epidemiología descriptiva, genética y prevención del cáncer , Nutrición, Eumetabolismo y Salud , Respiratorio , Enfermedades Digestivas y Microbiota , Obesidad y riesgo cardiovascular en pediatría , Investigación Metabólica y Maternofetal , Genética Cardiovascular , Investigación en Salud Vascular

Garre-Olmo J, Turró-Garriga O, Martí-Lluch R, Zacarías-Pons L, Alves-Cabratosa L, Serrano-Sarbosa D, Vilalta-Franch J, Ramos R

Changes in lifestyle resulting from confinement due to COVID-19 and depressive symptomatology: A cross-sectional a population-based study

COMPREHENSIVE PSYCHIATRY, 2021, 104, 152214-152214 dx.doi.org/10.1016/j.comppsych.2020.152214

Patología Cerebrovascular , Enfermedades Digestivas y Microbiota

Oliver L, Ramió-Pujol S, Amoedo J, Malagón M, Serrano M, Bahí A, Lluansí A, Torrealba L, Busquets D, PARDO, L., Serra-Pagès M, Aldeguer X, Garcia-Gil J

A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples

FRONTIERS IN MICROBIOLOGY, 2021, 12, 639948-639948 dx.doi.org/10.3389/fmicb.2021.639948

Enfermedades Digestivas y Microbiota

Lluansí A, Llirós M, Oliver L, Bahí A, Elias-Masiques N, Gonzalez M, Benejam P, Cueva E, Termes M, Ramió-Pujol S, Malagón M, Amoedo J, Serrano M, Busquets D, Torreabla L, Sabat M, Buxó M, Cambra M, Serra-Pagès M, Delgado-Aros S, García-Gil LJ, Elias I, Aldeguer X

In vitro Prebiotic Effect of Bread-Making Process in Inflammatory Bowel Disease Microbiome

FRONTIERS IN MICROBIOLOGY, 2021, 12, 716307-716307 dx.doi.org/10.3389/fmicb.2021.716307

Enfermedades Digestivas y Microbiota

Busquets D, Oliver L, Amoedo J, Ramió-Pujol S, Malagón M, Serrano M, Bahí A, Capdevila M, Lluansí A, Torrealba L, Peries L, Chavero R, Gilabert P, Sàbat M, Guardiola J, Serra-Pagès M, Garcia-Gil J, Aldeguer X

RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment

INFLAMMATORY BOWEL DISEASES, 2021, 27, 63-66 dx.doi.org/10.1093/ibd/izab273

Enfermedades Digestivas y Microbiota

Chaparro M, Garre A, Iborra M, Sierra-Ausín M, Barreiro-de Acosta M, Fernández-Clotet A, de Castro L, Boscá-Watts M, Casanova MJ, López-García A, Lorente R, Rodríguez C, Carbajo AY, Arroyo MT, Gutiérrez A, Hinojosa J, Martínez-Pérez T, Villoria A, Bermejo F, Busquets D, Camps B, Cañete F, Manceñido N, Monfort D, Navarro-Llavat M, Pérez-Calle JL, Ramos L, Rivero M, Angueira T, Camo Monterde P, Carpio D, García-de-la-Filia I, González-Muñoza C, Hernández L, Huguet JM, Morales VJ, Sicilia B, Vega P, Vera I, Zabana Y, Nos P, Suárez Álvarez P, Calviño-Suárez C, Ricart E, Hernández V, Mínguez M, Márquez L, Hervías Cruz D, Rubio Iturria S, Barrio J, Gargallo-Puyuelo C, Francés R, Hinojosa E, Del Moral M, Calvet X, Algaba A, Aldeguer X, Guardiola J, Mañosa M, Pajares R, Piqueras M, García-Bosch O, López Serrano P, Castro B, Lucendo AJ, Montoro M, Castro Ortiz E, Mesonero F, García-Planella E, Fuentes DA, Bort I, Delgado-Guillena P, Arias L, Iglesias A, Calvo M, Esteve M, Domènech E, Gisbert JP

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

JOURNAL OF CROHNS & COLITIS, 2021, 15, 1846-1851 dx.doi.org/10.1093/ecco-jcc/jjab070

Enfermedades Digestivas y Microbiota

Lopez-Siles M, Aldeguer X, Sabat-Mir M, Serra-Pagès M, Duncan SH, Flint HJ, Garcia-Gil LJ, Martinez-Medina M

Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.

World Journal Of Gastrointestinal Pathophysiology, 2020, 11, 64-77 dx.doi.org/10.4291/wjgp.v11.i3.64

12 3

Propietat intel·lectual

Xavier Aldeguer Mante

METHOD FOR DIAGNOSING COLORECTAL CANCER FROM A HUMAN FECES SAMPLE BY QUANTITIVE PCR, PRIMERS AND KIT

Número de publicació: WO2015132273 Data de publicació: 2015-09-11

Xavier Aldeguer Mante

METHOD FOR THE QUANTIFICATION OF FAECALIBACTERIUM PRAUSNITZII PHYLOGROUP I AND/OR PHYLOGROUP II MEMBERS AND THE USE THEREOF AS BIOMARKERS

Número de publicació: WO2017025617 Data de publicació: 2017-02-16

Directori

Projectes

Publicacions

Eradication of neoplastic Barrett's esophagus in patients with esophageal varices with a modified endoscopic mucosal resection technique and radiofrequency ablation

Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU

Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study

A case report of gastrointestinal histoplasmosis in a patient treated with infliximab

Changes in lifestyle resulting from confinement due to COVID-19 and depressive symptomatology: A cross-sectional a population-based study

A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples

In vitro Prebiotic Effect of Bread-Making Process in Inflammatory Bowel Disease Microbiome

RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.

Propietat intel·lectual

METHOD FOR DIAGNOSING COLORECTAL CANCER FROM A HUMAN FECES SAMPLE BY QUANTITIVE PCR, PRIMERS AND KIT

METHOD FOR THE QUANTIFICATION OF FAECALIBACTERIUM PRAUSNITZII PHYLOGROUP I AND/OR PHYLOGROUP II MEMBERS AND THE USE THEREOF AS BIOMARKERS

Formulari de contacte

Conoce el IDIBGI!